Mill Valley, CA, United States of America

W Michael Kavanaugh

This inventor holds 21 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Fibroblast Growth Factors. Top assignees: Chiron Corporation, Novartis Vaccines & Diagnostics, Gmbh, Five Prime Therapeutics, Inc.. Active years: 2000-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: W Michael Kavanaugh. Retrieved from https://idiyas.com/inventor/w-michael-kavanaugh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 11)

% Patents Active = 28.6

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 462(Granted Patents)

Location History:

Mill Valley, CA (US) (2000 - 2012)
Marin, CA (US) (2002 - 2015)
Orinda, CA (US) (2007 - 2015)

Company Filing History:

Novartis Vaccines & Diagnostics, Gmbh

patents

4 out of 77

Five Prime Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2000-2015

Loading Chart...

Areas of Expertise:

FGFR1 ECD Proteins

FGF-9

Hair Growth Methods

Coronary Artery Disease

Angiogenesis

EGFH2 Genes

NRG4 Inhibitors

FGF-2

KGF Polypeptides

Fibroblast Growth Factor Receptors

PI 3-Kinase Fusion Mutants

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9169313 - Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteins (2015-10-27),

2. 9149507 - Method of treating coronary artery disease by administering FGF-9 (2015-10-06),

3. 8685931 - Hair growth methods using FGFR3 extracellular domains (2014-04-01),

4. 8618052 - Method of treating coronary artery disease by administering FGF-5 (2013-12-31),

5. 8614183 - Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2 (2013-12-24),

6. 8445445 - Method of promoting hair growth using FGFR4 extracellular domains (2013-05-21),

7. 8178493 - Method for inducing angiogenesis in a heart of a patient (2012-05-15),

8. 7858584 - Angiogenically effective unit dose of FGF and method of administering (2010-12-28),

9. 7705117 - EGFH2 genes and gene products (2010-04-27),

10. 7531511 - Method for inducing angiogenesis or vascular perfusion in the myocardium comprising administering FGF-2 (2009-05-12),

11. 7511019 - Method of treating coronary artery disease by administering FGF-4 (2009-03-31),

12. 7476506 - Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers (2009-01-13),

13. 7276587 - Antibodies to EGFH2 polypeptides (2007-10-02),

14. 7265089 - KGF polypeptide compositions (2007-09-04),

15. 7259248 - Human FGF-21 polypeptides (2007-08-21),

Title: The Innovative Journey of W. Michael Kavanaugh

Introduction: W. Michael Kavanaugh, a distinguished inventor based in Mill Valley, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Kavanaugh's latest patents showcase his ingenuity and forward-thinking approach to innovation, with a focus on cutting-edge technologies in the digital realm and sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Kavanaugh has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only revolutionized industries but has also improved the lives of many through his inventions.

Collaborations: Throughout his career, Kavanaugh has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: W. Michael Kavanaugh's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his position as a trailblazing inventor in the technology sector. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.